Experimental Drug From Snake Venom For Acute Stroke Patients

Mar 31 2008 - 10:24am

Yale-New Haven Hospital is participating in a phase III research study in which a drug derived from the venom of the Malayan pit viper is being tested for the treatment of stroke. This new investigative drug is known as ancrod, and is being tested in eligible patients who come to the hospital within six hours of the start of stroke symptoms.


Psychological Distress Linked To Increased Risk Of Stroke

Mar 17 2008 - 1:51pm

Psychological distress, but not depression, may increase the risk of stroke. Previous studies have shown that stroke often leads to depression, but the evidence was mixed as to whether depression could lead to stroke.

"Stroke is among the leading causes of long-term disability and death worldwide," said study author Paul Surtees, PhD, of the University of Cambridge in the United Kingdom. "Understanding the mechanisms by which overall emotional health may increase stroke risk may inform stroke prevention and help identify those at increased stroke risk."